CF
HUMA icon

Corebridge Financial’s Humacyte HUMA Stock Holding History

Corebridge Financial’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,317
Closed -$75.6K – 1269
2025
Q1 		$75.6K Buy
44,317
+615
+1% +$2.31K ﹤0.01% 2582
2024
Q4 		$221K Sell
43,702
-3,300
-7% -$16.3K ﹤0.01% 2115
2024
Q3 		$256K Sell
47,002
-289
-0.6% -$1.91K ﹤0.01% 2078
2024
Q2 		$227K Buy
+47,291
New +$246K ﹤0.01% 2114

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Corebridge Financial's HUMA Position: Q2 2025 in Review

Corebridge Financial sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 44,317 shares — an estimated $75.6K sold.

Corebridge Financial first reported a position in HUMA in Q2 2024 and held it in 4 quarters. The position peaked at $256K in Q3 2024. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Corebridge Financial reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 44,317 Humacyte shares in Q2 2025, an estimated $75.6K.
  • Corebridge Financial first reported a position in Humacyte in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Humacyte position peaked at $256K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.